Roche's Q3 sales rise 20% on demand for cancer drugs, Tamiflu

BASEL, Switzerland (AP) - Roche Holding AG's third-quarter sales rose 20 per cent on demand for cancer drugs and Tamiflu, an antiviral being stockpiled by governments and individuals as a defence against a possible flu pandemic. Sales rose to 8.82 billion Swiss francs ($6....More